The lawsuit against Edwards Lifesciences for securities law violations is likely to negatively impact its stock price in the short term due to potential legal liabilities and investor concerns. The call to action for investors to contact Levi & Korsinsky suggests significant legal proceedings, which could lead to volatility in the stock.